Anteris as a surgical solution will look a lot more viable to health admins when it has the backing of a multi-billion, multi-national company.
Nobody wants to sue a 300, 400, 6,7,800 $mill company, you'll only get peanuts out them.
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial, page-75
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.55 |
Change
0.350(1.92%) |
Mkt cap ! $356.5M | |||
| Open | High | Low | Value | Volume |
| $18.20 | $18.62 | $18.20 | $68.60K | 3.738K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $18.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.90 | 500 | 1 |
View Market Depth
| Last trade - 15.57pm 27/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |